BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 1164 | Download: 794
Publication Name World Journal of Gastroenterology
Manuscript ID 10055
Country/Territory Germany
Received
2014-03-11 10:28
Peer-Review Started
2014-03-11 14:18
To Make the First Decision
2014-04-15 19:45
Return for Revision
2014-05-04 08:44
Revised
2014-05-26 00:00
Second Decision
2014-06-26 17:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-26 17:17
Articles in Press
2014-06-26 17:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-31 22:02
Publish the Manuscript Online
2014-11-17 15:12
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Randomized Controlled Trial
Article Title Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea
Manuscript Source Unsolicited Manuscript
All Author List Christoph G Dietrich, Tanja Kottmann and Manuela Alavi
Funding Agency and Grant Number
Corresponding Author Christoph G Dietrich, MD, PhD, Department of Medicine, Teaching Hospital of Aachen University RWTH, Bethlehem-Gesundheitszentrum, Steinfeldstraße 5, 52222 Stolberg, Rheinland, Germany. dietrich@bethlehem.de
Key Words Antibiotics-associated diarrhea; Probiotics; Lactobacillus casei
Core Tip The presented study used a large primary hospital cohort to test the effect of a commercially available probiotic drink in the prevention of antibiotic-associated diarrhea (AAD) in a decision-based manner. This is the first manufacturer-independent study showing a clear advantage of a probiotic drink containing Lactobacillus casei DN 114001 in AAD prevention. The study additionally contains a calculation of cost-effectiveness and identifies risk factors for AAD. In a second small pilot study, we compared for the first time two commercially available drinks in a head-to-head analysis.
Publish Date 2014-11-17 15:12
Citation Dietrich CG, Kottmann T, Alavi M. Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol 2014; 20(42): 15837-15844
URL http://www.wjgnet.com/1007-9327/full/v20/i42/15837.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i42.15837
Full Article (PDF) WJG-20-15837.pdf
Full Article (Word) WJG-20-15837.doc
Manuscript File 10055-Review.doc
Answering Reviewers 10055-Answering reviewers.pdf
Copyright License Agreement 10055-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 10055-Language certificate.pdf
Peer-review Report 10055-Peer review.pdf
Scientific Misconduct Check 10055-CorssCheck.jpg
Scientific Editor Work List 10055-Scientific editor work list.pdf